Table 3. Summary of literature review for nonCIMP-panes genes.
| Gene ID | Citation (et al.) | Patient (n) | Methylation (%) | Assay | Cancer Stage/Type | Ethnicity |
|---|---|---|---|---|---|---|
| APC |
Naghibalhossaini F5 |
110 |
92.6 |
MSP |
sporadic CRC |
Iranian |
| |
Krakowczyk L |
28 |
42 |
MSP |
Primary CRC |
Polish |
| |
Kim JC6 |
285 |
15.1 |
Pyrosequencing |
sporadic CRC |
Korean |
| |
Fu X7 |
12 |
47 |
MSP |
Seradited Adenoma |
Chinese |
| |
Lee BB4 |
243 |
27 |
MSP |
Stage I/II sporadic CRC |
Korean |
| |
Kamiyama H3 |
51 |
24 |
QMSP |
Primary CRC |
Japanese |
| |
Nagasaka T8 |
|
|
|
|
|
| 3OST2 |
Tokuyama Y9 |
487 |
82 |
COBRA |
Sporadic/ Lynch Syndrome |
White American |
| |
Gonzalo V10 |
129 |
57 |
MSP |
CRC tumors |
Japanese |
| |
Yi JM11 |
47 |
78.7 |
QMSP |
sporadic CRC |
Spanish |
| |
Chan TA12 |
|
|
|
|
|
| EVL |
Mokarram P13 |
777 |
> 50.0 |
qMSP |
Stage II CRC |
White American |
| |
Grady WM14 |
20 |
57 |
genome-wide |
Primary CRC |
White American |
| |
Yi JM11 |
102 |
> 65.0 |
MSP |
Sporadic CRC |
African American and Iranian |
| |
Chan TA12 |
|
86 |
|
|
White American |
| |
Ahlquist T17 |
|
|
|
|
|
| CD109 and ICAM5 |
Goel A15 |
777 |
|
qMSP |
Stage II CRC |
White American |
| |
Goel A18 |
20 |
|
genome-wide |
Primary CRC |
White American |
| |
Ruppenthal RD20 |
|
|
|
|
|
| PTEN |
Oster B21 |
154 |
0 |
MSP |
Sporadic CRC |
Norwegian |
| |
Okada T22 |
126 |
6 |
MSP |
Sporadic CRC |
White American |
| |
Derks S23 |
146 |
19.1 |
MSP |
Sporadic CRC |
White American |
| |
Ghoshal K24 |
|
|
|
|
|
| TWIST1 |
Hibi K25 |
73 |
63 |
MSP |
Primary CRC |
Brazilian |
| |
Hibi K26 |
48 |
> 40.0 |
HumanMethylation27 Array |
Malignant CRC lesions |
Denmark Cohort |
| |
Rawson JB29 |
319 |
|
|
Primary CRC |
Japanese |
| |
Ahn JB30 |
|
|
|
|
|
| DCC |
Tanaka J31 |
75 |
82.7 |
MSP |
Sporadic CRC |
White American |
| |
van Engeland M35 |
18 |
80 |
COBRA |
Primary CRC |
White American |
| |
Wagner KJ36 |
50 |
56 |
qMSP |
Primary CRC |
Japanese |
| |
Lee S34 |
36 |
44 |
qMSP |
Gastric Carcinoma |
Japanese |
| |
Tommasi S38 |
|
|
|
|
|
| SFRP1 |
Wahab AH39 |
1245 |
95 |
Association-based |
Primary CRC |
Canadian and Newfindland |
| |
An B37 |
161 |
99 |
Pyrosequencing |
Stage III sporadic CRC |
Korean |
| |
Osborn NK40 |
51 |
100 |
MSP |
sporadic CRC |
Japanese |
| |
Oster B21 |
|
|
|
|
|
| RASSF1A |
Schatz P41 |
222 |
20 |
MSP |
Sporadic CRC |
White American |
| |
Kim YH42 |
29 |
45 |
MSP |
Primary CRC |
European (UK) |
| |
Kim YH42 |
149 |
16.1 |
MSP |
Sporadic CRC |
Korean |
| |
Yi JM11 |
75 |
35 |
qMSP |
Metastatic CRC |
Italian |
| |
Varley KE43 |
36 |
47.2 |
MSP |
Primary CRC |
Egyptian |
| |
Varley KE43 |
18 |
51 |
MSP |
Distal Primary CRC |
Japanese |
| |
Kibriya MG44 |
|
|
|
|
|
| EYA4 |
Naghibalhossaini F5 |
10 |
80 |
MSP |
Primary CRC |
White American |
| |
Krakowczyk L |
30 |
N/A |
HumanMethylation27 Array |
Primary CRC |
Denmark |
| |
Kim JC6 |
12 |
N/A |
MALDI-TOF |
Primary CRC |
German |
| |
Fu X7 |
35 |
N/A |
Pyrosequencing |
Primary CRC |
Korean |
| |
Lee BB4 |
|
|
|
|
|
| LAMA1 |
Kamiyama H3 |
35 |
N/A |
Pyrosequencing |
Primary CRC |
Korean |
| |
Nagasaka T8 |
777 |
> 50.0 |
qMSP |
Stage II CRC |
White American |
| |
Tokuyama Y9 |
48 |
67 |
Biulfite patch PCR |
Primary CRC |
White American |
| |
Gonzalo V10 |
|
|
|
|
|
| KCNQ5 |
Yi JM11 |
48 |
92 |
biulfite patch PCR |
Primary CRC |
White American |
| |
Chan TA12 |
24 |
N/A |
q-PCR |
primary CRC |
Bangladesh |
| |
Mokarram P13 |
|
|
|
|
|
| ADHEF1 |
Grady WM14 |
35 |
N/A |
Pyrosequencing |
Primary CRC |
Korean |
| |
Yi JM11 |
48 |
> 60.0 |
HumanMethylation27 Array |
Malignant CRC lesions |
Denmark Cohort |
| |
Chan TA12 |
|
|
|
|
|
| TFPI2 |
Ahlquist T17 |
115 |
> 99.0 |
MSP |
Stage I to IV sporadic CRC |
White American |
| |
Goel A15 |
50 |
62 |
qMSP |
Primary CRC |
Japanese |
| Goel A18 | 35 | N/A | Pyrosequencing | Primary CRC | Korean |